Clinical Trial Update: Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Hydronidone Capsules in chronic hepatitis B with liver fibrosis; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Liver Fibrosis

Drugs mentioned

• Hydronidone Capsules

Snippet

Sponsor: Beijing Continent Pharmaceutical Co, Ltd. | Conditions: Liver Fibrosis | Phase 3 | Status: RECRUITING